Yamaguchi, O., Kaira, K., Shinomiya, S., Mouri, A., Hashimoto, K., Shiono, A., . . . Kagamu, H. (2020). Pre‐existing interstitial lung disease does not affect prognosis in non‐small cell lung cancer patients with PD‐L1 expression ≥50% on first‐line pembrolizumab. Thorac Cancer.
Styl ChicagoYamaguchi, Ou, et al. "Pre‐existing Interstitial Lung Disease Does Not Affect Prognosis in Non‐small Cell Lung Cancer Patients With PD‐L1 Expression ≥50% On First‐line Pembrolizumab." Thorac Cancer 2020.
Citace podle MLAYamaguchi, Ou, et al. "Pre‐existing Interstitial Lung Disease Does Not Affect Prognosis in Non‐small Cell Lung Cancer Patients With PD‐L1 Expression ≥50% On First‐line Pembrolizumab." Thorac Cancer 2020.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..